CEO of the medical group Fresenius: Stephan Sturm
Picture: dpa
The healthcare group Fresenius has carried out worse on the inventory alternate than virtually some other Dax firm. CEO Stephan Sturm explains why that is so and why Putin followers in Russia are handled like all different sufferers.
Mr. Sturm, in a couple of days you’ll meet Fresenius shareholders on the Annual Normal Assembly, who will most likely be something however happy with the share worth. Because you took workplace six years in the past, the worth has greater than halved, whereas the Dax has gained an excellent 50 %. What do you inform them?
I inform them that I’m not happy with the share worth both and that we’re working laborious to additional advance Fresenius and thus improve its worth.
Why is it?
There’s important skepticism about varied long-term investments that we now have approached. Be it in residence dialysis, be it within the biosimilars enterprise, be it in fertility drugs. These are all companies that aren’t but as worthwhile within the brief time period as we envisage within the medium to long run.
